chronic kidney disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) age 18-60 Years Without Gender Limitation; (2) maintenance hemodialysis patients (=3 months) with 2-3 dialysis sessions per week; (3) meeting the diagnostic criteria for intestinal dysfunction; (4) consenting to the use of fecal bacteria transplantation (FMT) for the treatment of intestinal dysfunction; Sign the informed consent form voluntarily.
Exclusion criteria
Exclusion criteria: (1) allergic or intolerant to probiotics; (2) use of antibiotics or Antifungal drugs during the interphase of treatment; oral probiotics (capsule or powder, etc.)15 days before treatment; (4) patients with advanced cancer; (5) patients with colonic obstructive disease; (6) severe cardiac dysfunction (Nyha class 3 or above) and poor control of hypertension (systolic blood pressure =180 mm hg or diastolic blood pressure =100 mm Hg) ; (7) life expectancy of less than 12 months; (8) has participated in or is currently participating in other clinical trials in the last 3 months (9) patients with stomach and peptic Ulcer Ulcerative Colitis; (10) conditions that researchers believe may affect compliance or affect the outcome of a trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of Faecal Flora genes; | — |
Secondary
| Measure | Time frame |
|---|---|
| FECAL metabonomics; | — |
Countries
China